Notice of Intent to Sole Source – Censis Technologies

The Sterile Processing Section within the Nursing Department at the National Institutes of Health (NIH) Clinical Center (CC) requires the renewal of a subscription for the current CensiTrac Environment as well as ScopeTrac Advance from Censis.

Product Service Code: 6515 Medical Instruments, Equipment, and Supplies

NAICS Code: 339112 Surgical and Medical Instrument Manufacturing

Place of Performance: Bethesda, MD 20892 USA

POTS: 25-009759

Description:

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.

The National Institutes of Health (NIH) intends to award a fixed price purchase order to the Censis Technologies, located at 4031 Aspen Grove Dr STE 350, Franklin, TN 37067, on a firm fixed price sole source award basis to provide Accreditation on-site evaluation services to the National Institutes of Health.

Below is a description of the item(s):

Description: SUT301R Subscription InstrumenTrac

Units: Each

Qty: 1

Catalog #: N/A

Description: MSGL0lb Subscription Renewal -Service+

Units: Each

Qty: 1

Catalog #: N/A

Description: SUBST02R ScopeTrac Stand Advanced Subscription Renewal

Units: Each

Qty: 1

Catalog #: N/A

The proposed vendor, Censis Technologies, is the only vendor that can provide the subscription and support for the program. There is no other company that can provide this service making them a Sole Source. This service includes ScopeTrac Advance as well as one week of onsite training.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by August 13, 2025 at 10am EST.